Atlas Trials

Salmon Peptide Fraction: Safety and Cardiometabolic Health

Clinical trial NCT05025462 · COMPLETED

Trial details

NCT number
NCT05025462
Sponsor
Laval University
Status
COMPLETED
Phase
Not Applicable
Study type
INTERVENTIONAL
Metabolic Syndrome
Start date
2021-11-01
Primary completion
2023-07-26
Enrollment
53

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.